290 related articles for article (PubMed ID: 24805089)
1. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.
Gupta V; Sreenivas V; Mehta M; Khaitan BK; Ramam M
Br J Dermatol; 2014 Nov; 171(5):1084-90. PubMed ID: 24805089
[TBL] [Abstract][Full Text] [Related]
2. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.
Krishna GS; Ramam M; Mehta M; Sreenivas V; Sharma VK; Khandpur S
Indian J Dermatol Venereol Leprol; 2013; 79(2):205-10. PubMed ID: 23442459
[TBL] [Abstract][Full Text] [Related]
3. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach.
Gupta V; Sreenivas V; Mehta M; Ramam M
Br J Dermatol; 2019 Mar; 180(3):580-585. PubMed ID: 30085349
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).
Lilly E; Lu PD; Borovicka JH; Victorson D; Kwasny MJ; West DP; Kundu RV
J Am Acad Dermatol; 2013 Jul; 69(1):e11-8. PubMed ID: 22365883
[TBL] [Abstract][Full Text] [Related]
5. Identification of categories at risk for high quality of life impairment in patients with vitiligo.
Sampogna F; Raskovic D; Guerra L; Pedicelli C; Tabolli S; Leoni L; Alessandroni L; Abeni D
Br J Dermatol; 2008 Aug; 159(2):351-9. PubMed ID: 18565189
[TBL] [Abstract][Full Text] [Related]
6. DLQI scores in vitiligo: reliability and validity of the Persian version.
Aghaei S; Sodaifi M; Jafari P; Mazharinia N; Finlay AY
BMC Dermatol; 2004 Aug; 4():8. PubMed ID: 15294022
[TBL] [Abstract][Full Text] [Related]
7. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
8. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre.
Kostopoulou P; Jouary T; Quintard B; Ezzedine K; Marques S; Boutchnei S; Taieb A
Br J Dermatol; 2009 Jul; 161(1):128-33. PubMed ID: 19298280
[TBL] [Abstract][Full Text] [Related]
9. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
[TBL] [Abstract][Full Text] [Related]
10. Development of a quality of life scale for vitiligo.
Şenol A; Yücelten AD; Ay P
Dermatology; 2013; 226(2):185-90. PubMed ID: 23735515
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16.
Szabó Á; Brodszky V; Rencz F
Br J Dermatol; 2022 Mar; 186(3):485-495. PubMed ID: 34724199
[TBL] [Abstract][Full Text] [Related]
12. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
[TBL] [Abstract][Full Text] [Related]
14. To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index.
Ingordo V; Cazzaniga S; Medri M; Raone B; Digiuseppe MD; Musumeci ML; Romano I; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Peccerillo F; Battarra VC; Sirna R; Patrizi A; Naldi L
Dermatology; 2014; 229(3):240-7. PubMed ID: 25358871
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitiligo on self-reported health-related quality of life.
Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
18. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
19. The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.
Komen L; van der Kraaij GE; van der Veen JP; de Rie MA; Wolkerstorfer A
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2145-51. PubMed ID: 25868111
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial burden of lichen planus pigmentosus is similar to vitiligo, but greater than melasma: A cross-sectional study from a tertiary-care center in north India.
Gupta V; Yadav D; Satapathy S; Upadhyay A; Mahajan S; Ramam M; Sharma VK
Indian J Dermatol Venereol Leprol; 2021; 87(3):341-347. PubMed ID: 33943064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
